Surg Cosmet Dermatol. 2014;6(3):233-237
Introduction: Several therapeutic modalities have been used to treat keloids and hypertrophic scars.
Objective: Treatment of keloids and hypertrophic scars with excision and intralesional injection of methotrexate.
Methods: Therapeutic intervention open study with 11 patients. Laboratory tests and photographs were carried out before, during, and after the treatment. From the seventh day after the excision of the lesions, the suture was injected weekly with methotrexate for six months. The weekly dose was 2.5 mg / 10cm suture, with a maximum dose of 5mg per patient. The evaluation was carried out by the physician and the patient.
Results: Six months after the end of the treatment, there was no recurrence of the lesion in five cases, partial recurrence in six cases and an absence of cases with total recurrence. No alterations were observed in the laboratory tests.
Conclusions: The maximum weekly dose of 5mg methotrexate for six months used in this pilot study to treat keloids and hypertrophic scars is safe and hinders recurrence. Further studies are needed to complement the present paper.
Keywords: KELOID; CICATRIX, HYPERTROPHIC; THERAPEUTICS; SKIN.